版权说明 操作指南
首页 > 成果 > 详情

Mechanisms of Xuefu Zhuyu Decoction in the treatment of coronary heart disease based on integrated metabolomics and network pharmacology approach

认领
导出
Link by DOI
反馈
分享
QQ微信 微博
成果类型:
期刊论文
作者:
Yang, Yang*;Su, Chang*;Zhang, Xiang-Zhuo*;Li, Jing*;Huang, Shu-Chun*;...
通讯作者:
Yang, Yang;Su, Chang;Zhang, Xiang-Zhuo;Li, Jing;Huang, Shu-Chun;Kuang, Hui-Fang;Zhang, Qiu-Yan
作者机构:
[Zhang, Xiang-Zhuo; Huang, Shu-Chun; Li, Jing; Yang, Yang; Kuang, Hui-Fang] Hunan Univ Chinese Med, Coll Tradit Chinese Med, Changsha 410208, Hunan, Peoples R China.
[Su, Chang] Hunan Univ Chinese Med, Coll Xiangxing, Changsha 410208, Hunan, Peoples R China.
[Zhang, Qiu-Yan] Hunan Univ Chinese Med, Sch Infirm, Changsha 410208, Hunan, Peoples R China.
通讯机构:
[Kuang, Hui-Fang; Su, Chang; Zhang, Xiang-Zhuo; Huang, Shu-Chun; Yang, Yang; Li, Jing] C
[Zhang, Qiu-Yan] S
College of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan 410208, China. Electronic address:
College of Xiangxing, Hunan University of Chinese Medicine, Changsha, Hunan 410208, China. Electronic address:
School Infirmary, Hunan University of Chinese Medicine, Changsha, Hunan 410208, China. Electronic address:
语种:
英文
关键词:
Coronary Heart Disease;Xuefu Zhuyu Decoction;Metabolomics;Network Pharmacology;Molecular Mechanism
期刊:
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
ISSN:
1570-0232
年:
2023
卷:
1223
页码:
123712
基金类别:
National Natural Science Foundation of China [81574039]; Hunan Provincial Natural Science Foundation of China [2020JJ4471]; Hunan Postgraduate Scientific Research Innovation Project [CX20210687]; Scientific research project of Hunan Provincial Department of Education [21A0253]
机构署名:
本校为第一机构
院系归属:
中医学院
摘要:
Coronary heart disease (CHD) has become the leading cause of mortality, morbidity, and disability worldwide. Though the therapeutic effect of Xuefu Zhuyu Decoction (XFZY) on CHD has been demonstrated in China, the active ingredients and molecular mechanisms of XFZY have not been elucidated. The purpose of the current study is to explore the molecular mechanisms of XFZY in the treatment of CHD via network pharmacology, metabolomics, and experimental validation. First, we established a CHD rat model by permanently ligating the left anterior descending coronary artery (LAD), and evaluated the the...

反馈

验证码:
看不清楚,换一个
确定
取消

成果认领

标题:
用户 作者 通讯作者
请选择
请选择
确定
取消

提示

该栏目需要登录且有访问权限才可以访问

如果您有访问权限,请直接 登录访问

如果您没有访问权限,请联系管理员申请开通

管理员联系邮箱:yun@hnwdkj.com